Table 2 Clinical data for the three groups of patients
From: Health-related quality of life in patients with dual diagnosis: clinical correlates
Clinical data | DD (N = 35) | SMI (N = 35) | SUD (N = 35) |
|---|---|---|---|
Psychiatric Diagnosis (% = 100) | |||
Schizophrenia | 45.7% | 80% | |
Bipolar Disorder | 28.6% | 14.3% | |
Major Depression Disorder | 25.7% | 5.7% | |
Age of psychiatric disorder onset | 24.82 ± 7.47 yr | 25.67 ± 8.07 yr | |
Mean duration of illness (yr) | 12.27 ± 7.81 yr | 14.09 ± 8.66 yr | |
Number of relatives with SUD | 0.35 ± 0.69 | 0.06 ± 0.23 | 0.23 ± 0.59 |
Number of relatives with psychiatric disorder | 0.65 ± 1.01 | 0.86 ± 0.87 | 0.49 ± 0.74 |
Number of suicidal attempts | 1.60 ± 3.2 | 0.34 ± 0.68 | 0.34 ± 0.87 |
Number of medical comorbidities a | 0.66 ± 1.05 | 0.57 ± 0.73 | 0.46 ± 0.78 |
Asthma/Allergy | 11.4% | 8.6% | 2.9% |
Triglycerides/Cholesterol | 11.4% | 25.7% | 2.9% |
Diabetes | 2.9% | 2.9% | 2.9% |
Obesity | 2.9% | ||
Hypertension | 2.9% | 8.6% | 2.9% |
HIV | 5.7% | 14.3% | |
Hepatitis B or C | 5.7% | 2.9% | 5.7% |
Others | 14.3% | 2.9% | 5.7% |
Daily number of medicationsa | 3.86 ± 1.83 | 3.03 ± 1.20 | 0.69 ± 1.10 |
Typical antipsychotics | 20.0% | 17.1% | 2.9% |
Atypical antipsychotics | 57.0%% | 60.0% | 5.7% |
Antidepressants | 28.6% | 25.7% | 11.4% |
Mood stabilizers | 25.0% | 31.4% | 8.6% |
Anxiolytics | 40% | 22.9% | 8.6% |
Other medication | 31.4% | 25.7% | 20% |
Clinical Global Impression (CGI) | 4.69 ± 0.96 | 4.50 ± 0.74 | 3.26 ± 1.01 |
Daily number of cigarettes | 18.34 ± 12.41 | 10.43 ± 12.44 | 14.74 ± 8.08 |
Fagerström score | 5.11 ± 2.52 | 2.89 ± 3.38 | 3.86 ± 2.48 |
No dependence | 14.3% | 54.3% | 17.1% |
Low dependence | 8.6% | 20.0% | |
Moderate dependence | 45.7% | 25.7% | 51.4% |
High dependence | 31.4% | 20% | 11.4% |
Daily Number of coffees (cups) | 1.77 ± 1.73 | 1.17 ± 1.44 | 1.66 ± 1.43 |
Other daily beverages with caffeine | 0.86 ± 1.00 | 0.71 ± 1.04 | 0.91 ± 1.26 |